|
[1]
|
Passweg, J.R., Baldomero, H., Ciceri, F., Corbacioglu, S., de la Cámara, R., Dolstra, H., et al. (2023) Hematopoietic Cell Transplantation and Cellular Therapies in Europe 2021. The Second Year of the SARS-CoV-2 Pandemic. A Report from the EBMT Activity Survey. Bone Marrow Transplantation, 58, 647-658. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Bolon, Y., Atshan, R., Allbee-Johnson, M., Estrada-Merly, N., Auletta, J.J., Broglie, L., et al. (2024) Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes. Transplantation and Cellular Therapy, 30, 921.e1-921.e22. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Fraebel, J., Engelhardt, B.G. and Kim, T.K. (2023) Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy, 29, 82-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Jaing, T., Wang, Y. and Chiu, C. (2024) Time to Rethink Bronchiolitis Obliterans Syndrome Following Lung or Hematopoietic Cell Transplantation in Pediatric Patients. Cancers, 16, Article 3715. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
赵玮, 石玉铸, 赵艳丽, 魏志杰, 孙瑞娟, 岳冠岚, 等. 儿童异基因造血干细胞移植后非感染性肺部并发症及相关气漏综合征临床分析[J]. 中国小儿血液与肿瘤杂志, 2022, 27(4): 226-231.
|
|
[6]
|
Uhlving, H.H., Skov, L., Buchvald, F., Heilmann, C., Grell, K., Ifversen, M., et al. (2019) Lung Clearance Index for Early Detection of Pulmonary Complications after Allo‐HSCT in Children. Pediatric Pulmonology, 54, 1029-1038. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Walther, S., Rettinger, E., Maurer, H.M., Pommerening, H., Jarisch, A., Sörensen, J., et al. (2020) Long‐Term Pulmonary Function Testing in Pediatric Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation. Pediatric Pulmonology, 55, 1725-1735. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Yoon, J., Chun, Y.H., Lee, J.W., Chung, N.G. and Cho, B. (2015) Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Pediatric Hematology/Oncology, 37, e462-e467. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Barker, A.F., Bergeron, A., Rom, W.N. and Hertz, M.I. (2014) Obliterative Bronchiolitis. New England Journal of Medicine, 370, 1820-1828. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bergeron, A., Chevret, S., Peffault de Latour, R., Chagnon, K., de Margerie-Mellon, C., Rivière, F., et al. (2018) Noninfectious Lung Complications after Allogeneic Haematopoietic Stem Cell Transplantation. European Respiratory Journal, 51, Article ID: 1702617. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
中国医师协会血液科医师分会, 中华医学会血液学分会. 造血干细胞移植后闭塞性细支气管炎综合征诊断与治疗中国专家共识(2022年版) [J]. 中华血液学杂志, 2022, 43(6): 441-447.
|
|
[12]
|
Shanthikumar, S., Gower, W.A., Srinivasan, S., Rayment, J.H., Robinson, P.D., Bracken, J., et al. (2024) Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine, 210, 262-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Hakim, A., Cooke, K.R., Pavletic, S.Z., Khalid, M., Williams, K.M. and Hashmi, S.K. (2018) Diagnosis and Treatment of Bronchiolitis Obliterans Syndrome Accessible Universally. Bone Marrow Transplantation, 54, 383-392. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Glanville, A.R., Benden, C., Bergeron, A., Cheng, G., Gottlieb, J., Lease, E.D., et al. (2022) Bronchiolitis Obliterans Syndrome after Lung or Haematopoietic Stem Cell Transplantation: Current Management and Future Directions. ERJ Open Research, 8, 00185-2022. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Bergeron, A., Godet, C., Chevret, S., Lorillon, G., Peffault de Latour, R., de Revel, T., et al. (2012) Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic SCT: Phenotypes and Prognosis. Bone Marrow Transplantation, 48, 819-824. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Fujii, N., Nakase, K., Asakura, S., Matsuo, K., Nawa, Y., Sunami, K., et al. (2014) Bronchiolitis Obliterans with Allogeneic Hematopoietic Cell Transplantation: A 10-Year Experience of the Okayama BMT Group. International Journal of Hematology, 99, 644-651. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Paz, H.L., Crilley, P., Patchefsky, A., Schiffman, R.L. and Brodsky, B. (1992) Bronchiolitis Obliterans after Autologous Bone Marrow Transplantation. Chest, 101, 775-778. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yomota, M., Yanagawa, N., Sakai, F., Yamada, Y., Sekiya, N., Ohashi, K., et al. (2019) Association between Chronic Bacterial Airway Infection and Prognosis of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. Medicine, 98, e13951. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Frankovich, J., Donaldson, S.S., Lee, Y., Wong, R.M., Amylon, M. and Verneris, M.R. (2001) High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Children with Primary Refractory and Relapsed Hodgkin’s Disease: Atopy Predicts Idiopathic Diffuse Lung Injury Syndromes. Biology of Blood and Marrow Transplantation, 7, 49-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Faraci, M., Ricci, E., Bagnasco, F., Pierri, F., Giardino, S., Girosi, D., et al. (2020) Imatinib Melylate as Second‐line Treatment of Bronchiolitis Obliterans after Allogenic Hematopoietic Stem Cell Transplantation in Children. Pediatric Pulmonology, 55, 631-637. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Au, B.K.C., Au, M.A. and Chien, J.W. (2011) Bronchiolitis Obliterans Syndrome Epidemiology after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 17, 1072-1078. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Vieira, A.G., Funke, V.A.M., Nunes, E.C., Frare, R. and Pasquini, R. (2014) Bronchiolitis Obliterans in Patients Undergoing Allogeneic Hematopoietic SCT. Bone Marrow Transplantation, 49, 812-817. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
孙若楠, 李泊涵, 郑德菲, 赵夏莹, 林子云, 胡昳歆, 等. 儿童异基因造血干细胞移植100天后闭塞性细支气管炎综合征临床特点及危险因素分析[J]. 临床儿科杂志, 2024, 42(2):1 39-145.
|
|
[24]
|
Soubani, A.O. and Uberti, J.P. (2007) Bronchiolitis Obliterans Following Haematopoietic Stem Cell Transplantation. European Respiratory Journal, 29, 1007-1019. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Jacobsohn, D.A. (2007) Acute Graft-versus-Host Disease in Children. Bone Marrow Transplantation, 41, 215-221. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Cuvelier, G.D.E., Nemecek, E.R., Wahlstrom, J.T., Kitko, C.L., Lewis, V.A., Schechter, T., et al. (2019) Benefits and Challenges with Diagnosing Chronic and Late Acute GVHD in Children Using the NIH Consensus Criteria. Blood, 134, 304-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Gazourian, L., Rogers, A.J., Ibanga, R., Weinhouse, G.L., Pinto‐Plata, V., Ritz, J., et al. (2014) Factors Associated with Bronchiolitis Obliterans Syndrome and Chronic Graft‐versus‐Host Disease after Allogeneic Hematopoietic Cell Transplantation. American Journal of Hematology, 89, 404-409. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Nakasone, H., Kanda, J., Yano, S., Atsuta, Y., Ago, H., Fukuda, T., et al. (2013) A Case-Control Study of Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation. Transplant International, 26, 631-639. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Weng, G., Fan, Z., Xue, H., Huang, F., Xu, N., Jin, H., et al. (2022) Haploidentical Donor Stem Cell Transplantation Had a Lower Incidence of Bronchiolitis Obliterans Syndrome Compared with Hla-Matched Sibling Donor Transplantation in Patients with Hematologic Malignancies: Benefit from ATG? Frontiers in Immunology, 13, Article 1036403. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yoshihara, S., Tateishi, U., Ando, T., Kunitoh, H., Suyama, H., Onishi, Y., et al. (2005) Lower Incidence of Bronchiolitis Obliterans in Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning Compared with Myeloablative Conditioning. Bone Marrow Transplantation, 35, 1195-1200. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Kwok, W., Liang, B., Lui, M.M.S., Tam, T.C.C., Sim, J.P.Y., Tse, E.W.C., et al. (2019) Rapid versus Gradual Lung Function Decline in Bronchiolitis Obliterans Syndrome after Haematopoietic Stem Cell Transplantation Is Associated with Survival Outcome. Respirology, 24, 459-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ahn, J.H., Jo, K., Song, J.W., Shim, T.S., Lee, S.W., Lee, J.S., et al. (2015) Prognostic Role of FEV1 for Survival in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation, 29, 1133-1139. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Chien, J.W., Martin, P.J., Flowers, M.E., Nichols, W.G. and Clark, J.G. (2004) Implications of Early Airflow Decline after Myeloablative Allogeneic Stem Cell Transplantation. Bone Marrow Transplantation, 33, 759-764. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Oishi, Y., Sohrabi, Y. and Xiao, P. (2024) Editorial: Metabolic Regulation of Macrophage Functions in Inflammation. Frontiers in Immunology, 15, Article 1369896. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Hou, F., Xiao, K., Tang, L. and Xie, L. (2021) Diversity of Macrophages in Lung Homeostasis and Diseases. Frontiers in Immunology, 12, Article 753940. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Yang, H., Cheng, H., Dai, R., Shang, L., Zhang, X. and Wen, H. (2023) Macrophage Polarization in Tissue Fibrosis. PeerJ, 11, e16092. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Kuroi, T., Fujii, N., Ichimura, K., Seike, K., Yamamoto, A., Kambara, Y., et al. (2021) Characterization of Localized Macrophages in Bronchiolitis Obliterans after Allogeneic Hematopoietic Cell Transplantation. International Journal of Hematology, 114, 701-708. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Herrero-Cervera, A., Soehnlein, O. and Kenne, E. (2022) Neutrophils in Chronic Inflammatory Diseases. Cellular & Molecular Immunology, 19, 177-191. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Yu, J. (2015) Postinfectious Bronchiolitis Obliterans in Children: Lessons from Bronchiolitis Obliterans after Lung Transplantation and Hematopoietic Stem Cell Transplantation. Korean Journal of Pediatrics, 58, 459-465. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Gassas, A., Krueger, J., Zaidman, I., Schechter, T., Craig‐Barnes, H., Ali, M., et al. (2016) Infections and Neutrophils in the Pathogenesis of Bronchiolitis Obliterans Syndrome in Children after Allogeneic Stem Cell Transplantation. Pediatric Transplantation, 20, 303-306. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Rosewich, M., Zissler, U.M., Kheiri, T., Voss, S., Eickmeier, O., Schulze, J., et al. (2015) Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans. Cytokine, 73, 156-162. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Aoki, A., Hirahara, K., Kiuchi, M. and Nakayama, T. (2021) Eosinophils: Cells Known for over 140 Years with Broad and New Functions. Allergology International, 70, 3-8. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Uemura, S., Kishimoto, K., Fujikawa, T., Nakamura, S., Kozaki, A., Saito, A., et al. (2024) Early Eosinophilia after Hematopoietic Stem Cell Transplantation Is Associated with Chronic Graft‐versus‐Host Disease. Pediatrics International, 66, e15836. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Williams, K.M., Pavletic, S.Z., Lee, S.J., Martin, P.J., Farthing, D.E., Hakim, F.T., et al. (2022) Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. Transplantation and Cellular Therapy, 28, 264.e1-264.e9. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Romagnani, S. (2000) T-Cell Subsets (Th1 versus Th2). Annals of Allergy, Asthma & Immunology, 85, 9-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Huangfu, L., Li, R., Huang, Y. and Wang, S. (2023) The IL-17 Family in Diseases: From Bench to Bedside. Signal Transduction and Targeted Therapy, 8, Article No. 402. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Ritzmann, F., Lunding, L.P., Bals, R., Wegmann, M. and Beisswenger, C. (2022) IL-17 Cytokines and Chronic Lung Diseases. Cells, 11, Article 2132. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Hodge, G., Hodge, S., Holmes-Liew, C., Reynolds, P.N. and Holmes, M. (2012) Bronchiolitis Obliterans Syndrome Is Associated with Increased Peripheral Blood Natural Killer and Natural Killer T-Like Granzymes, Perforin, and T-Helper-Type 1 Pro-Inflammatory Cytokines. The Journal of Heart and Lung Transplantation, 31, 888-895. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Xu, W., Yang, H., Liu, H., Tang, X., Xu, H., Li, H., et al. (2020) Bronchoalveolar Lavage T Cell Cytokine Profiles and Their Association with Lung Function in Children with Mycoplasma pneumoniae‐Associated Bronchiolitis Obliterans. Pediatric Pulmonology, 55, 2033-2040. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Fan, L., Benson, H.L., Vittal, R., Mickler, E.A., Presson, R., Fisher, A.J., et al. (2011) Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation. American Journal of Transplantation, 11, 911-922. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Heeger, P.S., Haro, M.C. and Jordan, S. (2024) Translating B Cell Immunology to the Treatment of Antibody-Mediated Allograft Rejection. Nature Reviews Nephrology, 20, 218-232. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Kuzmina, Z., Krenn, K., Petkov, V., Körmöczi, U., Weigl, R., Rottal, A., et al. (2013) CD19+CD21low B Cells and Patients at Risk for NIH-Defined Chronic Graft-versus-Host Disease with Bronchiolitis Obliterans Syndrome. Blood, 121, 1886-1895. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Cutler, C., Miklos, D., Kim, H.T., Treister, N., Woo, S., Bienfang, D., et al. (2006) Rituximab for Steroid-Refractory Chronic Graft-versus-Host Disease. Blood, 108, 756-762. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R.O., Burgos, F., Casaburi, R., et al. (2005) Interpretative Strategies for Lung Function Tests. European Respiratory Journal, 26, 948-968. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Williams, K.M., Hnatiuk, O., Mitchell, S.A., Baird, K., Gadalla, S.M., Steinberg, S.M., et al. (2014) NHANES III Equations Enhance Early Detection and Mortality Prediction of Bronchiolitis Obliterans Syndrome after Hematopoietic SCT. Bone Marrow Transplantation, 49, 561-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Abedin, S., Yanik, G.A., Braun, T., Pawarode, A., Magenau, J., Goldstein, S.C., et al. (2015) Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung. Biology of Blood and Marrow Transplantation, 21, 1127-1131. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Stahl, M., Joachim, C., Blessing, K., Hämmerling, S., Sommerburg, O., Latzin, P., et al. (2014) Multiple Breath Washout Is Feasible in the Clinical Setting and Detects Abnormal Lung Function in Infants and Young Children with Cystic Fibrosis. Respiration, 87, 357-363. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Stahl, M., Joachim, C., Kirsch, I., Uselmann, T., Yu, Y., Alfeis, N., et al. (2020) Multicentre Feasibility of Multiple-Breath Washout in Preschool Children with Cystic Fibrosis and Other Lung Diseases. ERJ Open Research, 6, 00408-2020. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Ratjen, F., Davis, S.D., Stanojevic, S., Kronmal, R.A., Hinckley Stukovsky, K.D., Jorgensen, N., et al. (2019) Inhaled Hypertonic Saline in Preschool Children with Cystic Fibrosis (SHIP): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet Respiratory Medicine, 7, 802-809. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Robinson, P.D., Goldman, M.D. and Gustafsson, P.M. (2009) Inert Gas Washout: Theoretical Background and Clinical Utility in Respiratory Disease. Respiration, 78, 339-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Gourgoulianis, K.I. and Molyvdas, P.A. (1998) Ventilation Distribution during Histamine Provocation. Journal of Applied Physiology, 85, 1198.
|
|
[62]
|
Tamburro, R.F., Cooke, K.R., Davies, S.M., Goldfarb, S., Hagood, J.S., Srinivasan, A., et al. (2021) Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. a National Institutes of Health Workshop Summary. Annals of the American Thoracic Society, 18, 381-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Duncan, C.N., Buonanno, M.R., Barry, E.V., Myers, K., Peritz, D. and Lehmann, L. (2008) Bronchiolitis Obliterans Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation, 41, 971-975. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Gunn, M.L.D., Godwin, J.D., Kanne, J.P., Flowers, M.E. and Chien, J.W. (2008) High-Resolution CT Findings of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation. Journal of Thoracic Imaging, 23, 244-250. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Foo, C.T., Langton, D., Thompson, B.R. and Thien, F. (2023) Functional Lung Imaging Using Novel and Emerging MRI Techniques. Frontiers in Medicine, 10, Article 1060940. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Kim, S.W., Rhee, C.K., Kang, H.S., Lee, H.Y., Kang, J.Y., Kim, S.J., et al. (2014) Diagnostic Value of Bronchoscopy in Patients with Hematologic Malignancy and Pulmonary Infiltrates. Annals of Hematology, 94, 153-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Williams, K.M. (2017) How I Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation. Blood, 129, 448-455. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Yanik, G.A., Mineishi, S., Levine, J.E., Kitko, C.L., White, E.S., Vander Lugt, M.T., et al. (2012) Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 18, 1044-1054. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Meignin, V., Thivolet‐Bejui, F., Kambouchner, M., Hussenet, C., Bondeelle, L., Mitchell, A., et al. (2018) Lung Histopathology of Non‐infectious Pulmonary Complications after Allogeneic Haematopoietic Stem Cell Transplantation. Histopathology, 73, 832-842. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Holbro, A., Lehmann, T., Girsberger, S., Stern, M., Gambazzi, F., Lardinois, D., et al. (2013) Lung Histology Predicts Outcome of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 19, 973-980. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
White, D.A., Wong, P.W. and Downey, R. (2000) The Utility of Open Lung Biopsy in Patients with Hematologic Malignancies. American Journal of Respiratory and Critical Care Medicine, 161, 723-729. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Roca, J., Granena, A., Rodriguez-Roisin, R., Alvarez, P., Agusti-Vidal, A. and Rozman, C. (1982) Fatal Airway Disease in an Adult with Chronic Graft-versus-Host Disease. Thorax, 37, 77-78. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Filipovich, A.H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J.R., Lee, S.J., et al. (2005) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation, 11, 945-956. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Jagasia, M.H., Greinix, H.T., Arora, M., Williams, K.M., Wolff, D., Cowen, E.W., et al. (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. the 2014 Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation, 21, 389-401.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Wolff, D., Gerbitz, A., Ayuk, F., Kiani, A., Hildebrandt, G.C., Vogelsang, G.B., et al. (2010) Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD. Biology of Blood and Marrow Transplantation, 16, 1611-1628. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
中华医学会血液学分会干细胞应用学组. 慢性移植物抗宿主病诊断与治疗中国专家共识(2024年版) [J]. 中华血液学杂志, 2024, 45(8): 713-726.
|
|
[77]
|
Hildebrandt, G.C., Fazekas, T., Lawitschka, A., Bertz, H., Greinix, H., Halter, J., et al. (2011) Diagnosis and Treatment of Pulmonary Chronic GVHD: Report from the Consensus Conference on Clinical Practice in Chronic GVHD. Bone Marrow Transplantation, 46, 1283-1295. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Bergeron, A., Chevret, S., Chagnon, K., Godet, C., Bergot, E., Peffault de Latour, R., et al. (2015) Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation. American Journal of Respiratory and Critical Care Medicine, 191, 1242-1249. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Even‐Or, E., Ghandourah, H., Ali, M., Krueger, J., Sweezey, N.B. and Schechter, T. (2018) Efficacy of High‐Dose Steroids for Bronchiolitis Obliterans Syndrome Post Pediatric Hematopoietic Stem Cell Transplantation. Pediatric Transplantation, 22, e13155. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Kavaliunaite, E. and Aurora, P. (2019) Diagnosing and Managing Bronchiolitis Obliterans in Children. Expert Review of Respiratory Medicine, 13, 481-488. [Google Scholar] [CrossRef] [PubMed]
|
|
[81]
|
Penack, O., Marchetti, M., Ruutu, T., Aljurf, M., Bacigalupo, A., Bonifazi, F., et al. (2020) Prophylaxis and Management of Graft versus Host Disease after Stem-Cell Transplantation for Haematological Malignancies: Updated Consensus Recommendations of the European Society for Blood and Marrow Transplantation. The Lancet Haematology, 7, e157-e167. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Williams, K.M., Cheng, G., Pusic, I., Jagasia, M., Burns, L., Ho, V.T., et al. (2016) Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 22, 710-716. [Google Scholar] [CrossRef] [PubMed]
|
|
[83]
|
Liu, Z., Liao, F., Zhu, J., Zhou, D., Heo, G.S., Leuhmann, H.P., et al. (2022) Reprogramming Alveolar Macrophage Responses to TGF-β Reveals CCR2+ Monocyte Activity That Promotes Bronchiolitis Obliterans Syndrome. Journal of Clinical Investigation, 132, e159229. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
Inamoto, Y., Martin, P.J., Onstad, L.E., Cheng, G., Williams, K.M., Pusic, I., et al. (2021) Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 27, 759.e1-759.e8. [Google Scholar] [CrossRef] [PubMed]
|
|
[85]
|
Hao, X., Peng, C., Lian, W., Liu, H. and Fu, G. (2022) Effect of Azithromycin on Bronchiolitis Obliterans Syndrome in Posttransplant Recipients: A Systematic Review and Meta-Analysis. Medicine, 101, e29160. [Google Scholar] [CrossRef] [PubMed]
|
|
[86]
|
Cheng, G., Bondeelle, L., Gooley, T., He, Q., Jamani, K., Krakow, E.F., et al. (2020) Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 26, 392-400. [Google Scholar] [CrossRef] [PubMed]
|
|
[87]
|
Przepiorka, D., Luo, L., Subramaniam, S., Qiu, J., Gudi, R., Cunningham, L.C., et al. (2019) FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-versus-Host Disease. The Oncologist, 25, e328-e334. [Google Scholar] [CrossRef] [PubMed]
|
|
[88]
|
Baccelli, F., Gottardi, F., Muratore, E., Leardini, D., Grasso, A.G., Gori, D., et al. (2024) Ruxolitinib for the Treatment of Acute and Chronic Graft-versus-Host Disease in Children: A Systematic Review and Individual Patient Data Meta-analysis. Bone Marrow Transplantation, 59, 765-776. [Google Scholar] [CrossRef] [PubMed]
|
|
[89]
|
Jagasia, M., Perales, M., Schroeder, M.A., Ali, H., Shah, N.N., Chen, Y., et al. (2020) Ruxolitinib for the Treatment of Steroid-Refractory Acute GVHD (REACH1): A Multicenter, Open-Label Phase 2 Trial. Blood, 135, 1739-1749. [Google Scholar] [CrossRef] [PubMed]
|
|
[90]
|
Wang, Y.M., Teusink-Cross, A., Elborai, Y., Krupski, M.C., Nelson, A.S., Grimley, M.S., et al. (2022) Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Transplantation, 106, 412-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[91]
|
DeFilipp, Z., Kim, H.T., Yang, Z., Noonan, J., Blazar, B.R., Lee, S.J., et al. (2022) Clinical Response to Belumosudil in Bronchiolitis Obliterans Syndrome: A Combined Analysis from 2 Prospective Trials. Blood Advances, 6, 6263-6270. [Google Scholar] [CrossRef] [PubMed]
|
|
[92]
|
Brownback, K.R., Thomas, L.A., McGuirk, J.P., Ganguly, S., Streiler, C. and Abhyankar, S. (2017) Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome Due to Graft-versus-Host-Disease. Lung, 195, 781-788. [Google Scholar] [CrossRef] [PubMed]
|
|
[93]
|
Williams, K.M., Inamoto, Y., Im, A., Hamilton, B., Koreth, J., Arora, M., et al. (2021) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. the 2020 Etiology and Prevention Working Group Report. Transplantation and Cellular Therapy, 27, 452-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[94]
|
Chianese, M., Screm, G., Salton, F., Confalonieri, P., Trotta, L., Barbieri, M., et al. (2024) Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows. Pharmaceuticals, 17, Article 709. [Google Scholar] [CrossRef] [PubMed]
|
|
[95]
|
Bos, S., De Sadeleer, L.J., Vanstapel, A., Beeckmans, H., Sacreas, A., Yserbyt, J., et al. (2021) Antifibrotic Drugs in Lung Transplantation and Chronic Lung Allograft Dysfunction: A Review. European Respiratory Review, 30, Article ID: 210050. [Google Scholar] [CrossRef] [PubMed]
|
|
[96]
|
Solomon, J.J., Danoff, S.K., Woodhead, F.A., Hurwitz, S., Maurer, R., Glaspole, I., et al. (2023) Safety, Tolerability, and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study. The Lancet Respiratory Medicine, 11, 87-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[97]
|
Chen, S., Zhao, K., Lin, R., Wang, S., Fan, Z., Huang, F., et al. (2019) The Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study. eBioMedicine, 49, 213-222. [Google Scholar] [CrossRef] [PubMed]
|
|
[98]
|
Del Fante, C., Galasso, T., Bernasconi, P., Scudeller, L., Ripamonti, F., Perotti, C., et al. (2016) Extracorporeal Photopheresis as a New Supportive Therapy for Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation. Bone Marrow Transplantation, 51, 728-731. [Google Scholar] [CrossRef] [PubMed]
|
|
[99]
|
Lucid, C.E., Savani, B.N., Engelhardt, B.G., Shah, P., Clifton, C., Greenhut, S.L., et al. (2010) Extracorporeal Photopheresis in Patients with Refractory Bronchiolitis Obliterans Developing after Allo-SCT. Bone Marrow Transplantation, 46, 426-429. [Google Scholar] [CrossRef] [PubMed]
|
|
[100]
|
Brownback, K.R., Simpson, S.Q., Pitts, L.R., Polineni, D., McGuirk, J.P., Ganguly, S., et al. (2015) Effect of Extracorporeal Photopheresis on Lung Function Decline for Severe Bronchiolitis Obliterans Syndrome Following Allogeneic Stem Cell Transplantation. Journal of Clinical Apheresis, 31, 347-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[101]
|
Hefazi, M., Langer, K.J., Khera, N., Adamski, J., Roy, V., Winters, J.L., et al. (2018) Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions. Biology of Blood and Marrow Transplantation, 24, 1906-1913. [Google Scholar] [CrossRef] [PubMed]
|
|
[102]
|
Cheng, G., Edelman, J.D., Madtes, D.K., Martin, P.J. and Flowers, M.E.D. (2014) Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 20, 1169-1175. [Google Scholar] [CrossRef] [PubMed]
|
|
[103]
|
Kliman, D.S., Kotecha, S.R., Abelson, D.C., Snell, G.I., Glanville, A.R. and Ma, D.D.F. (2019) Favorable Outcome of Lung Transplantation for Severe Pulmonary Graft versus Host Disease: An Australian Multicenter Case Series. Transplantation, 103, 2602-2607. [Google Scholar] [CrossRef] [PubMed]
|
|
[104]
|
Holm, A.M., Riise, G.C., Hansson, L., Brinch, L., Bjørtuft, Ø., Iversen, M., et al. (2012) Lung Transplantation for Bronchiolitis Obliterans Syndrome after Allo-SCT. Bone Marrow Transplantation, 48, 703-707. [Google Scholar] [CrossRef] [PubMed]
|
|
[105]
|
Liang, J., Chen, Y., Zhou, J., Li, H., Zheng, M., Liu, F., et al. (2022) Lung Transplantation for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation: A Retrospective Single-Center Study. Annals of Translational Medicine, 10, 659-659. [Google Scholar] [CrossRef] [PubMed]
|
|
[106]
|
Koenecke, C., Hertenstein, B., Schetelig, J., Van Biezen, A., Dammann, E., Gratwohl, A., et al. (2010) Solid Organ Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Multicenter Study of the EBMT. American Journal of Transplantation, 10, 1897-1906. [Google Scholar] [CrossRef] [PubMed]
|
|
[107]
|
Bos, S., Murray, J., Marchetti, M., Cheng, G., Bergeron, A., Wolff, D., et al. (2024) ERS/EBMT Clinical Practice Guidelines on Treatment of Pulmonary Chronic Graft-versus-Host Disease in Adults. European Respiratory Journal, 63, Article ID: 2301727. [Google Scholar] [CrossRef] [PubMed]
|
|
[108]
|
Tonga, K.O. and Oliver, B.G. (2023) Effectiveness of Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Therapy: Focusing on Traditional Medical Practices. Journal of Clinical Medicine, 12, Article 4815. [Google Scholar] [CrossRef] [PubMed]
|